Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (61-70 of 405) with videos related to

Pageof 41
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
The perils of data sharing, meta-analyses, and estimating cardiovascular riskThomas A Marciniak, Dan Atar, Victor Serebruany
American Journal of Therapeutics|April 11, 2012
Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of StatinsDan Atar, Seleen Ong, Peter J Lansberg
American Journal of Therapeutics|August 9, 2011
Cost effectiveness of drug-eluting stents as compared with bare metal stents in patients with coronary artery diseaseTorbjørn Wisløff, Dan Atar, Ivar Sønbø Kristiansen
The American Journal of Medicine|August 24, 2019
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?Thomas A Marciniak, Dan Atar, Victor Serebruany
Annals of the Rheumatic Diseases|March 19, 2010
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritisDan Atar, Kåre Inge Birkeland, Till Uhlig
Cerebrovascular Diseases (Basel, Switzerland)|August 7, 2007
Asymptomatic myocardial infarction prior to ischemic stroke?Jesper K Jensen, Dan Atar, Hans Mickley
Anatolian Journal of Cardiology|July 16, 2024
The Interplay of Atherothrombotic Factors and the Evolving Landscape of Atherosclerotic Cardiovascular Disease: Comprehensive Insights from Recent StudiesJamilah Alrahimi, Fatima Ali Ahmed, Dan Atar
Journal of Electrocardiology|January 21, 2021
Is RBBB the new LBBB? Are we going to repeat the same mistakes?Yochai Birnbaum, Kjell Nikus, Dan Atar, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 22, 2008
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?Victor L Serebruany, Dan Atar, Dan F Hanley
Polish Archives of Internal Medicine|March 1, 2019
Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implementVictor L Serebruany, Thomas A Marciniak, Dan Atar
Pageof 41

Showing results (61-70 of 405) with videos related to

Sort By:
Pageof 41
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
The perils of data sharing, meta-analyses, and estimating cardiovascular riskThomas A Marciniak, Dan Atar, Victor Serebruany
American Journal of Therapeutics|April 11, 2012
Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of StatinsDan Atar, Seleen Ong, Peter J Lansberg
American Journal of Therapeutics|August 9, 2011
Cost effectiveness of drug-eluting stents as compared with bare metal stents in patients with coronary artery diseaseTorbjørn Wisløff, Dan Atar, Ivar Sønbø Kristiansen
The American Journal of Medicine|August 24, 2019
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?Thomas A Marciniak, Dan Atar, Victor Serebruany
Annals of the Rheumatic Diseases|March 19, 2010
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritisDan Atar, Kåre Inge Birkeland, Till Uhlig
Cerebrovascular Diseases (Basel, Switzerland)|August 7, 2007
Asymptomatic myocardial infarction prior to ischemic stroke?Jesper K Jensen, Dan Atar, Hans Mickley
Anatolian Journal of Cardiology|July 16, 2024
The Interplay of Atherothrombotic Factors and the Evolving Landscape of Atherosclerotic Cardiovascular Disease: Comprehensive Insights from Recent StudiesJamilah Alrahimi, Fatima Ali Ahmed, Dan Atar
Journal of Electrocardiology|January 21, 2021
Is RBBB the new LBBB? Are we going to repeat the same mistakes?Yochai Birnbaum, Kjell Nikus, Dan Atar, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 22, 2008
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?Victor L Serebruany, Dan Atar, Dan F Hanley
Polish Archives of Internal Medicine|March 1, 2019
Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implementVictor L Serebruany, Thomas A Marciniak, Dan Atar
Pageof 41